Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants

Published:2006-08 Issue:8 Volume:27 Page:627-632
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Barbaro Daniele,Boni Giuseppe,Meucci Giuseppe,Simi Umberto,Lapi Paola,Orsini Paola,Pasquini Cristina,Turco Anna,Mariani Giuliano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid Carcinoma

2. Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation?

3. A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma

4. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice

5. Usefulness of Recombinant Human Thyrotropin in the Radiometabolic Treatment of Selected Patients with Thyroid Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies;European Journal of Endocrinology;2023-01-19

2. TSH-β gene polymorphism in Saudi patients with thyroid cancer: A case-control study;Saudi Pharmaceutical Journal;2022-11

3. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH;European Journal of Endocrinology;2020-10

4. The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer;PLOS ONE;2015-07-31

5. Comparative Effectiveness in Thyroid Cancer: Key Questions and How to Answer Them;Cancer Treatment and Research;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3